- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Indian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
5
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
5 companies
NATCO Pharma
Market Cap: ₹185.4b
A pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹1,020.25
7D
4.4%
1Y
-16.8%
Jenburkt Pharmaceuticals
Market Cap: ₹5.7b
Researches and develops, manufactures, and markets pharmaceutical and healthcare products in India.
524731
₹1,340.65
7D
0.9%
1Y
53.4%
Gennex Laboratories
Market Cap: ₹3.1b
Engages in manufacturing and selling of bulk drugs, intermediates, and biotech products.
531739
₹13.43
7D
-9.4%
1Y
-3.2%
Quest Laboratories
Market Cap: ₹1.6b
Engages in the manufacture and sale of pharmaceutical formulations in India.
QUESTLAB
₹96.00
7D
8.1%
1Y
-31.2%
JFL Life Sciences
Market Cap: ₹513.1m
Engages in the manufacture and sale of pharmaceutical products in India and internationally.
JFLLIFE
₹15.55
7D
-2.8%
1Y
-13.1%